 | | WUL | | 表記: | 8-BROMANYL-2-[[(3S)-3-OXIDANYLPYRROLIDIN-1-YL]METHYL]-3H-[1]BENZOFURO[3,2-D]PYRIMIDIN-4-ONE | | 組成式: | C15 H14 Br N3 O3 | | SMILES: | Brc4cc3c(oc1c3N=C(NC1=O)CN2CCC(O)C2)cc4 | | InChi: | InChI=1S/C15H14BrN3O3/c16-8-1-2-11-10(5-8)13-14(22-11)15(21)18-12(17-13)7-19-4-3-9(20)6-19/h1-2,5,9,20H,3-4,6-7H2,(H,17,18,21)/t9-/m0/s1 | | 別名: | (S)-8-BROMO-2-((3-HYDROXYPYRROLIDIN-1-YL)METHYL) | | 定義日: | 2012-03-20 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 8-bromo-2-{[(3S)-3-hydroxypyrrolidin-1-yl]methyl}[1]benzofuro[3,2-d]pyrimidin-4(3H)-one |
|
 | | RRT | | 表記: | (R)-RETRO-THIORPHAN | | 組成式: | C12 H15 N O3 S | | SMILES: | O=C(O)CC(=O)NC(Cc1ccccc1)CS | | InChi: | InChI=1S/C12H15NO3S/c14-11(7-12(15)16)13-10(8-17)6-9-4-2-1-3-5-9/h1-5,10,17H,6-8H2,(H,13,14)(H,15,16)/t10-/m1/s1 | | 別名: | 3-{[(1R)-1-BENZYL-2-SULFANYLETHYL]AMINO}-3-OXOPROPANOIC ACID | | 定義日: | 2005-04-08 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 3-{[(1R)-1-benzyl-2-sulfanylethyl]amino}-3-oxopropanoic acid |
|
 | | SLC | | 表記: | SELENO-CAPTOPRIL | | 組成式: | C9 H13 N O3 Se | | SMILES: | O=C(O)C1N(C(=O)C(=C)C[SeH])CCC1 | | InChi: | InChI=1S/C9H13NO3Se/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h7,14H,1-5H2,(H,12,13)/t7-/m0/s1 | | 別名: | 1-[2-(SELANYLMETHYL)ACRYLOYL]-L-PROLINE | | 定義日: | 2011-03-22 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 1-[2-(selanylmethyl)acryloyl]-L-proline |
|
 | | TTF | | 表記: | 4,4,4-TRIFLUORO-1-THIEN-2-YLBUTANE-1,3-DIONE | | 組成式: | C8 H5 F3 O2 S | | SMILES: | O=C(c1sccc1)CC(=O)C(F)(F)F | | InChi: | InChI=1S/C8H5F3O2S/c9-8(10,11)7(13)4-5(12)6-2-1-3-14-6/h1-3H,4H2 | | 別名: | 2-THENOYLTRIFLUOROACETONE | | 定義日: | 2005-05-18 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 4,4,4-trifluoro-1-thiophen-2-ylbutane-1,3-dione |
|
 | | RRX | | 表記: | (3R)-beta,beta-caroten-3-ol | | 組成式: | C40 H56 O | | SMILES: | OC2CC(=C(C=CC(=CC=CC(=CC=CC=C(C=CC=C(C=CC1=C(C)CCCC1(C)C)C)C)C)C)C(C)(C)C2)C | | InChi: | InChI=1S/C40H56O/c1-30(18-13-20-32(3)23-25-37-34(5)22-15-27-39(37,7)8)16-11-12-17-31(2)19-14-21-33(4)24-26-38-35(6)28-36(41)29-40(38,9)10/h11-14,16-21,23-26,36,41H,15,22,27-29H2,1-10H3/b12-11+,18-13+,19-14+,25-23+,26-24+,30-16+,31-17+,32-20+,33-21+/t36-/m1/s1 | | 別名: | beta-Cryptoxanthin | | 定義日: | 2014-05-01 | | 最終更新日: | 2021-03-01 | | 公開日: | 2014-09-03 | | 識別子（ID）: | (3R)-beta,beta-caroten-3-ol |
|
 | | TTG | | 表記: | 2-(1-DIMETHYLAMINOMETHYL-2-HYDROXY-8-HYDROXYMETHYL-9-OXO-9,11-DIHYDRO-INDOLIZINO[1,2-B]QUINOLIN-7-YL)-2-HYDROXY-BUTYRIC ACID | | 組成式: | C23 H25 N3 O6 | | SMILES: | O=C(O)C(O)(C=4C=C3c2nc1ccc(O)c(c1cc2CN3C(=O)C=4CO)CN(C)C)CC | | InChi: | InChI=1S/C23H25N3O6/c1-4-23(32,22(30)31)16-8-18-20-12(9-26(18)21(29)15(16)11-27)7-13-14(10-25(2)3)19(28)6-5-17(13)24-20/h5-8,27-28,32H,4,9-11H2,1-3H3,(H,30,31)/t23-/m0/s1 | | 別名: | HYDROLYZED PRODUCT OF TOPOTECAN | | 定義日: | 2002-01-15 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (2S)-2-{1-[(dimethylamino)methyl]-2-hydroxy-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl}-2-hydroxybutanoic acid |
|
 | | XRA | | 表記: | 2-[4-(furan-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine | | 組成式: | C19 H21 N5 O4 | | SMILES: | O=C(N3CCN(c2nc1cc(OC)c(OC)cc1c(n2)N)CC3)c4occc4 | | InChi: | InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22) | | 別名: | Prazosin | | 定義日: | 2010-09-24 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone |
|
 | | O2Y | | 表記: | 3-[(carboxymethyl)sulfanyl]pyridine-2-carboxylic acid | | 組成式: | C8 H7 N O4 S | | SMILES: | O=C(CSc1c(nccc1)C(=O)O)O | | InChi: | InChI=1S/C8H7NO4S/c10-6(11)4-14-5-2-1-3-9-7(5)8(12)13/h1-3H,4H2,(H,10,11)(H,12,13) | | 別名: | 3-(carboxymethylthio)picolinic acid | | 定義日: | 2019-06-05 | | 最終更新日: | 2021-03-01 | | 公開日: | 2019-09-18 | | 識別子（ID）: | 3-[(carboxymethyl)sulfanyl]pyridine-2-carboxylic acid |
|
 | | VGL | | 表記: | PYRAZINE-2-CARBOXYLIC ACID | | 組成式: | C5 H4 N2 O2 | | SMILES: | O=C(O)c1nccnc1 | | InChi: | InChI=1S/C5H4N2O2/c8-5(9)4-3-6-1-2-7-4/h1-3H,(H,8,9) | | 別名: | PYRAZINOIC ACID | | 定義日: | 2009-09-15 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | pyrazine-2-carboxylic acid |
|
 | | TTI | | 表記: | 2'-deoxy-5-telluroxouridine 5'-(dihydrogen phosphate) | | 組成式: | C9 H13 N2 O8 P Te | | SMILES: | [Te]=C2C(=O)NC(=O)N(C1OC(C(O)C1)COP(=O)(O)O)C2 | | InChi: | InChI=1S/C9H13N2O8PTe/c12-4-1-7(19-5(4)3-18-20(15,16)17)11-2-6(21)8(13)10-9(11)14/h4-5,7,12H,1-3H2,(H,10,13,14)(H2,15,16,17)/t4-,5+,7+/m0/s1 | | 別名: | 5-Tellurium-deoxyuridine-5'-phosphate | | 定義日: | 2008-12-03 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 2'-deoxy-5-telluroxouridine 5'-(dihydrogen phosphate) |
|
 | | TEX | | 表記: | (2S,5S)-9-[(3R)-3,7-dimethylocta-1,6-dien-3-yl]-5-(hydroxymethyl)-1-methyl-2-(propan-2-yl)-1,2,4,5,6,8-hexahydro-3H-[1,4]diazonino[7,6,5-cd]indol-3-one | | 組成式: | C27 H39 N3 O2 | | SMILES: | c1cc(c3c2c1N(C)C(C(=O)NC(Cc2cn3)CO)C(C)C)C(C)([C@H]=C)CCC=C(/C)C | | InChi: | InChI=1S/C27H39N3O2/c1-8-27(6,13-9-10-17(2)3)21-11-12-22-23-19(15-28-24(21)23)14-20(16-31)29-26(32)25(18(4)5)30(22)7/h8,10-12,15,18,20,25,28,31H,1,9,13-14,16H2,2-7H3,(H,29,32)/t20-,25-,27-/m0/s1 | | 別名: | Teleocidin A 1 | | 定義日: | 2016-03-31 | | 最終更新日: | 2021-03-01 | | 公開日: | 2016-09-28 | | 識別子（ID）: | (2S,5S)-9-[(3R)-3,7-dimethylocta-1,6-dien-3-yl]-5-(hydroxymethyl)-1-methyl-2-(propan-2-yl)-1,2,4,5,6,8-hexahydro-3H-[1,4]diazonino[7,6,5-cd]indol-3-one |
|
 | | VGP | | 表記: | (1R)-1,4-anhydro-6-deoxy-1-[(6R)-8-ethenyl-1,6-dihydroxy-10,12-dimethoxy-6H-dibenzo[c,h]chromen-4-yl]-D-galactitol | | 組成式: | C27 H28 O9 | | SMILES: | OC1C(OC(C(O)C)C1O)c5c4c3OC(O)c2cc(C=C)cc(OC)c2c3cc(OC)c4c(O)cc5 | | InChi: | InChI=1S/C27H28O9/c1-5-12-8-15-19(17(9-12)33-3)14-10-18(34-4)21-16(29)7-6-13(20(21)25(14)36-27(15)32)26-23(31)22(30)24(35-26)11(2)28/h5-11,22-24,26-32H,1H2,2-4H3/t11-,22-,23-,24+,26-,27-/m1/s1 | | 別名: | pregilvocarcin V | | 定義日: | 2010-11-30 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (1R)-1,4-anhydro-6-deoxy-1-[(6R)-8-ethenyl-1,6-dihydroxy-10,12-dimethoxy-6H-dibenzo[c,h]chromen-4-yl]-D-galactitol |
|
 | | SLN | | 表記: | 1-(4-AZIDO-2-NITROPHENYL)AMINO-3-(1-OXYL-2,2,5,5-TETRAMETHYLPYRROLIDINYL-3-CARBAMIDO)-2-PROPYLDISPHOSPHATE | | 組成式: | C18 H29 N7 O11 P2 | | SMILES: | [O-][N+](=O)c1cc(/N=[N+]=[N-])ccc1NCC(OP(=O)(O)OP(=O)(O)O)CNC(=O)C2C(N(O)C(C)(C)C2)(C)C | | InChi: | InChI=1S/C18H29N7O11P2/c1-17(2)8-13(18(3,4)25(17)29)16(26)21-10-12(35-38(33,34)36-37(30,31)32)9-20-14-6-5-11(22-23-19)7-15(14)24(27)28/h5-7,12-13,20,29H,8-10H2,1-4H3,(H,21,26)(H,33,34)(H2,30,31,32)/t12-,13-/m0/s1 | | 別名: | (SL-NANDP) | | 定義日: | 2003-04-22 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (1S)-2-[(4-azido-2-nitrophenyl)amino]-1-[({[(3R)-1-hydroxy-2,2,5,5-tetramethylpyrrolidin-3-yl]carbonyl}amino)methyl]ethyl trihydrogen diphosphate |
|
 | | RE5 | | 表記: | L-Glutamate Tenofovir | | 組成式: | C14 H21 N6 O7 P | | SMILES: | C[CH](Cn1cnc2c(N)ncnc12)OC[P](O)(=O)N[CH](CCC(O)=O)C(O)=O | | InChi: | InChI=1S/C14H21N6O7P/c1-8(4-20-6-18-11-12(15)16-5-17-13(11)20)27-7-28(25,26)19-9(14(23)24)2-3-10(21)22/h5-6,8-9H,2-4,7H2,1H3,(H,21,22)(H,23,24)(H2,15,16,17)(H2,19,25,26)/t8-,9+/m1/s1 | | 別名: | (2~{S})-2-[[[(2~{R})-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-oxidanyl-phosphoryl]amino]pentanedioic acid | | 定義日: | 2020-09-28 | | 最終更新日: | 2021-03-01 | | 公開日: | 2021-01-13 | | 識別子（ID）: | (2~{S})-2-[[[(2~{R})-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-oxidanyl-phosphoryl]amino]pentanedioic acid |
|
 | | SLO | | 表記: | 2-[(3Z)-6-fluoranyl-2-methyl-3-[(4-methylsulfonylphenyl)methylidene]inden-1-yl]ethanoic acid | | 組成式: | C20 H17 F O4 S | | SMILES: | O=S(=O)(c1ccc(cc1)/C=C3c2ccc(F)cc2C(=C3C)CC(=O)O)C | | InChi: | InChI=1S/C20H17FO4S/c1-12-17(9-13-3-6-15(7-4-13)26(2,24)25)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- | | 別名: | sulindac sulfone | | 定義日: | 2011-05-19 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid |
|
 | | QZM | | 表記: | 2-[2-[(cyclohexylmethyl-$l^{3}-oxidanyl)carbonylamino]propan-2-yl]-~{N}-[2-(5-methoxy-4-oxidanyl-cyclohexa-1,3,5-trien-1-yl)ethyl]-5-oxidanyl-6-oxidanylidene-pyrimidine-4-carboxamide | | 組成式: | C25 H28 N4 O7 | | SMILES: | c1(ccc(cc1OC)CCNC(=O)C3=C(C(=O)NC(C(C)(C)NC(=O)OCc2ccccc2)=N3)O)O | | InChi: | InChI=1S/C25H28N4O7/c1-25(2,29-24(34)36-14-16-7-5-4-6-8-16)23-27-19(20(31)22(33)28-23)21(32)26-12-11-15-9-10-17(30)18(13-15)35-3/h4-10,13,30-31H,11-12,14H2,1-3H3,(H,26,32)(H,29,34)(H,27,28,33) | | 別名: | SJ000986192 | | 定義日: | 2020-01-17 | | 最終更新日: | 2021-03-01 | | 公開日: | 2021-02-10 | | 識別子（ID）: | benzyl [2-(5-hydroxy-4-{[2-(4-hydroxy-3-methoxyphenyl)ethyl]carbamoyl}-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]carbamate |
|
 | | QZP | | 表記: | 4-(2-methylpropyl)benzoic acid | | 組成式: | C11 H14 O2 | | SMILES: | c1c(CC(C)C)ccc(C(O)=O)c1 | | InChi: | InChI=1S/C11H14O2/c1-8(2)7-9-3-5-10(6-4-9)11(12)13/h3-6,8H,7H2,1-2H3,(H,12,13) | | 別名: | 4-isobutylbenzoic acid | | 定義日: | 2020-01-20 | | 最終更新日: | 2021-03-01 | | 公開日: | 2021-01-20 | | 識別子（ID）: | 4-(2-methylpropyl)benzoic acid |
|
 | | VH2 | | 表記: | N-[5-[(4-BROMOPHENYL)METHYL]-4-HYDROXY-1,3-THIAZOL-2-YL]NAPHTHALENE-1-SULFONAMIDE | | 組成式: | C20 H15 Br N2 O3 S2 | | SMILES: | Oc1nc(N[S](=O)(=O)c2cccc3ccccc23)sc1Cc4ccc(Br)cc4 | | InChi: | InChI=1S/C20H15BrN2O3S2/c21-15-10-8-13(9-11-15)12-17-19(24)22-20(27-17)23-28(25,26)18-7-3-5-14-4-1-2-6-16(14)18/h1-11,24H,12H2,(H,22,23) | | 別名: | PITSTOP 2 | | 定義日: | 2010-11-25 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | N-[5-[(4-bromophenyl)methyl]-4-hydroxy-1,3-thiazol-2-yl]naphthalene-1-sulfonamide |
|
 | | RSH | | 表記: | 3-DEOXY-D-LYXO-HEXONIC ACID | | 組成式: | C6 H12 O6 | | SMILES: | O=C(O)C(O)CC(O)C(O)CO | | InChi: | InChI=1S/C6H12O6/c7-2-5(10)3(8)1-4(9)6(11)12/h3-5,7-10H,1-2H2,(H,11,12)/t3-,4+,5-/m1/s1 | | 別名: | D-2-KETO-3-DEOXYGALACTONATE | | 定義日: | 2004-07-19 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 3-deoxy-D-lyxo-hexonic acid |
|
 | | TFO | | 表記: | [2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID | | 組成式: | C9 H14 N5 O4 P | | SMILES: | O=P(O)(O)COC(C)Cn1c2ncnc(c2nc1)N | | InChi: | InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1 | | 別名: | TENOFOVIR | | 定義日: | 2004-04-21 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonic acid |
|
 | | WW2 | | 表記: | cyclohexyl (S)-methylphosphonofluoridoate | | 組成式: | C7 H14 F O2 P | | SMILES: | O=P(F)(OC1CCCCC1)C | | InChi: | InChI=1S/C7H14FO2P/c1-11(8,9)10-7-5-3-2-4-6-7/h7H,2-6H2,1H3/t11-/m0/s1 | | 別名: | Cyclosarin | | 定義日: | 2009-10-22 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | cyclohexyl (S)-methylphosphonofluoridate |
|
 | | TFX | | 表記: | 2-[4-(dimethylamino)phenyl]-3,6-dimethyl-1,3-benzothiazol-3-ium | | 組成式: | C17 H19 N2 S | | SMILES: | s2c1cc(ccc1[n+](c2c3ccc(N(C)C)cc3)C)C | | InChi: | InChI=1S/C17H19N2S/c1-12-5-10-15-16(11-12)20-17(19(15)4)13-6-8-14(9-7-13)18(2)3/h5-11H,1-4H3/q+1 | | 別名: | Thioflavin T | | 定義日: | 2010-05-12 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 2-[4-(dimethylamino)phenyl]-3,6-dimethyl-1,3-benzothiazol-3-ium |
|
 | | V2A | | 表記: | neoseptin 3 | | 組成式: | C29 H34 N2 O4 | | SMILES: | C(c1ccccc1)CC(C(OC(C)(C)C)=O)NC(=O)c2ccc(c(c2)CCc3ccc(cc3)O)N | | InChi: | InChI=1S/C29H34N2O4/c1-29(2,3)35-28(34)26(18-12-20-7-5-4-6-8-20)31-27(33)23-14-17-25(30)22(19-23)13-9-21-10-15-24(32)16-11-21/h4-8,10-11,14-17,19,26,32H,9,12-13,18,30H2,1-3H3,(H,31,33)/t26-/m0/s1 | | 別名: | tert-butyl (2S)-2-({4-amino-3-[2-(4-hydroxyphenyl)ethyl]benzene-1-carbonyl}amino)-4-phenylbutanoate | | 定義日: | 2020-06-17 | | 最終更新日: | 2021-03-01 | | 公開日: | 2020-07-01 | | 識別子（ID）: | tert-butyl (2S)-2-({4-amino-3-[2-(4-hydroxyphenyl)ethyl]benzene-1-carbonyl}amino)-4-phenylbutanoate |
|
 | | 5YB | | 表記: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine | | 組成式: | C24 H27 N5 O7 | | SMILES: | C(c1ccc(C(=N)N)cc1)(=O)NCCC(=O)NC(CC(=O)O)C(=O)NC(Cc2ccccc2)C(=O)O | | InChi: | InChI=1S/C24H27N5O7/c25-21(26)15-6-8-16(9-7-15)22(33)27-11-10-19(30)28-17(13-20(31)32)23(34)29-18(24(35)36)12-14-4-2-1-3-5-14/h1-9,17-18H,10-13H2,(H3,25,26)(H,27,33)(H,28,30)(H,29,34)(H,31,32)(H,35,36)/t17-,18-/m0/s1 | | 別名: | Ro-435054 | | 定義日: | 2016-01-05 | | 最終更新日: | 2021-03-01 | | 公開日: | 2016-02-03 | | 識別子（ID）: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine |
|
 | | ARD | | 表記: | C15-(R)-METHYLTHIENYL RAPAMYCIN | | 組成式: | C55 H81 N O12 S | | SMILES: | O=C2C(=O)C5(OC(CC(c1sc(cc1)C)C(=CC=CC=CC(C)CC(C(=O)C(OC)C(O)C(=CC(C(=O)CC(OC(=O)C3N2CCCC3)C(C)CC4CCC(O)C(OC)C4)C)C)C)C)CCC5C)O | | InChi: | InChI=1S/C55H81NO12S/c1-32-16-12-11-13-17-33(2)42(48-24-20-39(8)69-48)30-41-22-19-38(7)55(64,68-41)52(61)53(62)56-25-15-14-18-43(56)54(63)67-46(35(4)28-40-21-23-44(57)47(29-40)65-9)31-45(58)34(3)27-37(6)50(60)51(66-10)49(59)36(5)26-32/h11-13,16-17,20,24,27,32,34-36,38,40-44,46-47,50-51,57,60,64H,14-15,18-19,21-23,25-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,40+,41+,42-,43+,44-,46+,47-,50-,51+,55-/m1/s1 | | 別名: | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | | 定義日: | 1999-07-08 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21R,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10-methoxy-6,8,12,14,20,26-hexamethyl-21-(5-methylthiophen-2-yl)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone |
|
